GLENMARK PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Largecap | BSE
Here's the live share price of Glenmark Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.72₹ -14.05
As on Sep 30, 2025, 4:01 PM IST
Glenmark Pharmaceuticals Price Performance
Today's LowToday's High
₹1,932.80₹1,980.00
₹1,944.80
52 Weeks' Low52 Weeks' High
₹1,274.70₹2,286.15
₹1,944.80
Open Price
₹1,958.90
Prev. Close
₹1,958.85
Volume
10,439
Over the last 5 years, the share price of Glenmark Pharmaceuticals has gained 32.16% CAGR. Over the past year, the corresponding return has been 16.20%.
Glenmark Pharmaceuticals’s current P/E of 72.82x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Glenmark Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Glenmark Pharmaceuticals | -3.64 | 0.86 | 10.93 | 28.90 | 16.20 | 71.05 | 32.16 |
| Sun Pharmaceutical Industries | -1.91 | 2.34 | -4.58 | -5.71 | -16.94 | 19.02 | 26.17 |
| Divi's Laboratories | -6.14 | -6.76 | -16.62 | 2.35 | 4.28 | 15.51 | 13.26 |
| Torrent Pharmaceuticals | -1.56 | 0.41 | 5.47 | 13.03 | 5.78 | 32.14 | 20.76 |
| Cipla | -1.64 | -5.34 | -0.16 | 4.04 | -9.14 | 10.46 | 14.17 |
| Dr. Reddy's Laboratories | -6.02 | -3.98 | -4.24 | 6.67 | -9.05 | 12.35 | 3.45 |
| Mankind Pharma | -5.22 | -3.57 | 4.57 | -1.13 | -3.67 | 19.48 | 11.27 |
| Zydus Lifesciences | -5.86 | -0.66 | -0.56 | 12.15 | -7.89 | 36.53 | 20.04 |
| Lupin | -4.23 | 1.18 | -0.87 | -1.81 | -12.29 | 41.39 | 13.79 |
| Alkem Laboratories | -2.61 | 2.01 | 9.50 | 11.84 | -10.81 | 18.13 | 14.23 |
| Aurobindo Pharma | -2.35 | 5.69 | -4.50 | -4.48 | -25.80 | 28.53 | 6.35 |
| Abbott India | -2.48 | -8.02 | -17.22 | -2.66 | 1.18 | 15.55 | 12.33 |
| Biocon | -5.19 | -3.32 | -4.15 | 0.50 | -6.11 | 5.43 | -5.31 |
| Laurus Labs | -7.47 | -2.12 | 16.15 | 40.71 | 81.94 | 18.00 | 24.01 |
| GlaxoSmithKline Pharmaceuticals | -3.80 | -5.33 | -21.60 | -4.95 | -3.62 | 23.07 | 11.02 |
| Anthem Biosciences | -7.03 | -6.32 | 4.52 | 4.52 | 4.52 | 1.48 | 0.89 |
| Ipca Laboratories | -3.50 | -1.49 | -3.08 | -3.42 | -10.10 | 13.70 | 4.43 |
| Cohance Lifesciences | -2.31 | -2.68 | -9.17 | -18.29 | -25.17 | 24.97 | 18.27 |
| Gland Pharma | -1.35 | 6.51 | 8.65 | 28.00 | 10.88 | -1.70 | 1.80 |
| Ajanta Pharma | -5.70 | -2.21 | -6.83 | -8.33 | -25.04 | 23.94 | 17.40 |
Over the last one year, Glenmark Pharmaceuticals has gained 16.20% compared to peers like Sun Pharmaceutical Industries (-16.94%), Divi's Laboratories (4.28%), Torrent Pharmaceuticals (5.78%). From a 5 year perspective, Glenmark Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (26.17%) and Divi's Laboratories (13.26%).
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,053.85 | 1,995.51 |
| 10 | 2,083.43 | 2,019.27 |
| 20 | 2,035.55 | 2,029.44 |
| 50 | 2,066.39 | 1,994.74 |
| 100 | 1,828.31 | 1,885.63 |
| 200 | 1,645.58 | 1,729.99 |
Glenmark Pharmaceuticals News
Glenmark Pharmaceuticals Share Holding Pattern
In the latest quarter, Glenmark Pharmaceuticals saw a drop in promoter holding to 46.64%, while DII stake increased to 17.64%, FII holding fell to 20.62%, and public shareholding moved down to 15.05% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Glenmark Pharmaceuticals Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| HDFC Mid-Cap Opportunities Fund - Regular Plan | 1,23,94,203 | 2.87 | 2,384.52 |
| Invesco India Mid Cap Fund | 16,76,417 | 4 | 322.53 |
| Invesco India Contra Fund | 16,62,235 | 1.68 | 319.8 |
| Invesco India Large & Mid Cap Fund | 13,42,939 | 3.18 | 258.37 |
| Kotak Equity Arbitrage Fund - Regular Plan | 11,39,250 | 0.3 | 219.18 |
| HDFC Large and Mid Cap Fund - Regular Plan | 10,48,046 | 0.77 | 201.63 |
| Mirae Asset Healthcare Fund | 9,86,043 | 6.79 | 189.7 |
| Mahindra Manulife Multi Cap Fund | 9,35,000 | 3.2 | 179.88 |
| HDFC Balanced Advantage Fund - Regular Plan | 8,85,046 | 0.17 | 170.27 |
| Bandhan Small Cap Fund | 8,50,877 | 1.12 | 163.7 |
Glenmark Pharmaceuticals Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Glenmark Pharmaceuticals Options
Glenmark Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 27, 2025, 12:40 AM IST | Glenmark Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 27, 2025, 12:33 AM IST | Glenmark Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Sep 26, 2025, 4:34 PM IST | Glenmark Pharma - Corporate Action-Board approves Dividend |
| Sep 26, 2025, 4:19 PM IST | Glenmark Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Held On 26Th September, 2025 |
| Sep 24, 2025, 9:10 PM IST | Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/11/1977 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24299MH1977PLC019982 and registration number is 019982. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 9226.41 Cr. and Equity Capital is Rs. 28.22 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressB/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai Maharashtra 400026
- Contact
Management
- Mr. Glenn SaldanhaChairman & Managing Director
- Mrs. Cherylann PintoExecutive Director - Corporate Affairs
- Mr. V S ManiExecutive Director & Global CFO
- Mrs. B E SaldanhaNon Executive Director
- Ms. Saira RamasastryInd. Non-Executive Director
- Mrs. Vijayalakshmi IyerInd. Non-Executive Director
- Mr. Rajesh V DesaiInd. Non-Executive Director
- Mr. Dipankar BhattacharjeeInd. Non-Executive Director
FAQs on Glenmark Pharmaceuticals Share Price
What is the share price of Glenmark Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Glenmark Pharmaceuticals is ₹1,944.80 as on Sep 30, 2025.
What kind of stock is Glenmark Pharmaceuticals?
The Glenmark Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
What is the Market Cap of Glenmark Pharmaceuticals?
The market cap of Glenmark Pharmaceuticals is ₹54,882.41 Cr as on Sep 30, 2025.
What are today's High and Low prices of Glenmark Pharmaceuticals?
Today’s highest and lowest price of Glenmark Pharmaceuticals are ₹1,980.00 and ₹1,932.80.
What are the 52 Week High and 52 Week Low of Glenmark Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Glenmark Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Glenmark Pharmaceuticals is ₹2,286.15 and 52-week low of Glenmark Pharmaceuticals is ₹1,274.70 as on Sep 30, 2025.
How has the Glenmark Pharmaceuticals performed historically in terms of returns?
The Glenmark Pharmaceuticals has shown returns of -0.72% over the past day, 0.86% for the past month, 10.93% over 3 months, 16.2% over 1 year, 71.05% across 3 years, and 32.16% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Glenmark Pharmaceuticals?
P/E ratio of and PB ratio of Glenmark Pharmaceuticals are 72.82 and 6.50 on Sep 30, 2025. While the company gives a dividend yield of 0.13 per annum.
Trending In Market
Mutual Funds Screener
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data